We are thrilled to officially welcome Jennifer Fox as our Chief Legal Officer, effective today. Her #leadership will be instrumental in guiding our legal strategy and supporting Myriad's mission to advance health and well-being for all. We look forward to the exciting journey ahead! Learn more: https://lnkd.in/gTCwMF_j #teamMyriad #welcome
Myriad Genetics
Biotechnology Research
Salt Lake City, Utah 85,498 followers
We're a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all.
About us
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
- Website
-
http://www.myriad.com/
External link for Myriad Genetics
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Salt Lake City, Utah
- Type
- Public Company
- Founded
- 1991
- Specialties
- Molecular Diagnostics, Personalized Medicine, Prognostic Medicine, Companion Diagnostics, Carrier Screen, Pharmacogenomics, Genetic Testing, Hereditary Cancer, Prostate Cancer, Breast Cancer, Prenatal Screen, Precision Medicine, Ovarian Cancer, Pancreatic Cancer, and Gender Testing
Locations
Employees at Myriad Genetics
Updates
-
📢 Breast density is a critical factor in #breastcancer risk, yet many women are unaware of its significance. In fact, 44% of women do not understand breast density and 63% are unaware of the connection between breast density and cancer risk. Dense breast tissue is normal, but it can slightly elevate the risk of developing breast cancer. As new FDA guidelines take effect this September, all breast imaging facilities will be required to inform patients if they have dense breasts – a vital step forward in supporting women to take charge of their health. For women with dense breasts, additional screening methods like ultrasound or MRI, alongside mammography, may improve cancer detection rates. Knowledge is power – Our MyRisk® Hereditary Cancer Test with RiskScore analyzes density, among many other factors, in this comprehensive breast cancer risk assessment. Learn more: https://lnkd.in/gtkpWJFr We look forward to helping amplify this important new FDA legislation and how Myriad can help, so all women can be informed about their breast health. 💪 #womenshealth #breastcancerawareness #oncology
📣 📣 DenseBreast-info.org (DBI) 👏 applauds 👏 the implementation of a National Breast Density Reporting Standard. The Federal legislation, which goes into effect on September 10, 2024, requires all mammography facilities to provide a patient with either “not dense” or “dense” standardized notification developed by the FDA’s National Mammography Quality Assurance Advisory Committee (NMQAAC). GE HealthCare, Bayer, Myriad Genetics, Hologic, Inc., Volpara Health, Beekley Medical, iCAD, CMR Naviscan, Bracco Imaging, VasoHealthcare, MagView. https://lnkd.in/gzCPF8Q4
-
-
🌟 Proud to have partnered with Black Physicians of Utah (BPOU) for their recent Back to School Mental Health #event, with 57 students and their families in attendance learning how to cope with #stress and #anxiety in today's digital age. Our own Rachel Fuggins, ONC, and Ebony Savage, MH, shared valuable insights on #mentalhealth management, including how GeneSight can help families who live with more severe mental health conditions. We are grateful to Dr. Richard Ferguson, MD, MBA, Founder of BPOU, and the rest of the BPOU team for their continued commitment to addressing health disparities and fostering an inclusive healthcare environment. Together, we're making a difference! To learn more about Black Physicians of Utah, visit their website: https://bpou.org/. #healthequity #backtoschool #teamMyriad
-
-
Today we announced that Myriad management will participate in two upcoming investor healthcare conferences: 🔵 The Wells Fargo Healthcare Conference in a fireside chat featuring Scott Leffler, Chief Financial Officer, on September 4, 2024 at 1:30 PM ET 🔵 The Morgan Stanley Healthcare Conference in a fireside chat featuring Paul Diaz, President and CEO, on September 5, 2024 at 7 AM ET. Read more: https://lnkd.in/gigd-txf #leadership #teamMyriad #events
-
-
📰 Excited to share that our own Dr. Dale Muzzey, PhD and Chief Scientific Officer, helped contribute to this insightful piece published by Inside Precision Medicine. This article sheds light on the critical advancements in Minimal Residual Disease (MRD) detection, a field that is helping transform #oncology and patient outcomes. We are committed to leading the way in #innovation and precision medicine - Thank you, Dr. Muzzey, for helping underscore our dedication to advancing MRD research and enhancing patient care. 🔗 Read the full article: #mrd #teamMyriad #cancercare
-
🌟 Ready for #EpicUGM next week? Be sure to stop by our booth to learn how Myriad Genetics is pioneering the future of #genetictesting and precision medicine. Our team will be there to answer your questions, discuss our #innovation and how it can benefit your practice and patients, and explore how we can collaborate to transform healthcare. See below to learn more about our integration solutions and request additional information. We look forward to connecting with you in 📍Wisconsin! Epic Chaz Strubbe Clinton Maddox Chuck Kulchar Alex Paisley-Lasso Deanine Hlavin Leslie Wilkie
EMR Integration Capabilities | Myriad Genetics
https://myriad.com
-
🏆 Thanks again for all our employees, partners and the entire Myriad Genetics community for helping make our recognition in TIME as one of America's Best Midsize Companies of 2024 possible. Our success is driven by the incredible dedication of all our teams, who work hard to improve the lives of patients through evidence-based science, technology and #innovation. Check out the full list here: https://lnkd.in/gAguYxBU. Together, we are proud to continue making a difference! #companyculture #teamMyriad
-
-
🎉👶 So excited that SneakPeek, our test that predicts fetal sex as early as 6 weeks into pregnancy with over 99% accuracy, is now available at CVS Pharmacy stores nationwide! This milestone means that expectant parents can conveniently access this test in-store, empowering themselves with the knowledge they need on their journey to #parenthood. A big thank you to all our #teamMyriad colleagues and partners who helped make this expansion possible 💪 and to our own Sarah Cacia for this great video. Visit your local CVS to find SneakPeek: https://lnkd.in/geEms2HF. #womenshealth #pregnancy #genetictesting
-
We announced financial results for our second quarter ended June 30, 2024 and raised our previously issued financial guidance on business performance for the full-year 2024. "We are very proud to have delivered another quarter of strong double digit year-over-year revenue growth in the second quarter of 2024," said Paul Diaz, President and CEO. "Our year-to-date 2024 revenue growth of 13% year-over-year, following our 11% year-over-year revenue growth in the calendar year 2023, and our 15% year-over-year revenue growth in the second quarter 2024, demonstrate the sustainability of our organic growth and gives us the confidence to raise our long-term revenue growth target to 12%." Read more from our official press release below:
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
investor.myriad.com
-
Ashley D., whose experience using our MyRisk Hereditary Cancer Test led to her discovery that she was positive for the BRCA2 gene mutation, was recently featured by a local NBC News affiliate, where she emphasized the importance of #genetictesting in identifying hereditary cancer risks and how this knowledge can inform care, aid in early intervention and help healthcare providers develop personalized treatment. See the video below 👇: #hereditarycancer #knowyourrisk #breastcancer
Survey finds many unaware of breast cancer risk
https://www.youtube.com/
Affiliated pages
Similar pages
Browse jobs
Stock
MYGN
NASDAQ
20 minutes delay
$25.36
-2.1 (-7.648%)
- Open
- 26.93
- Low
- 24.74
- High
- 27.04
Data from Refinitiv
See more info on